8-K current report · filed Nov 4, 2026

agilon health, inc. (AGL) 8-K Current Report: November 4, 2026

Item 2.02Item EX-99.1AGL overview

Short answer

agilon health, inc. (AGL) filed an 8-K current report with the SEC on November 4, 2026 reporting Item 2.02 (Results of Operations and Financial Condition), Item EX-99.1 (Exhibit EX-99.1). Press release covers agilon health’s third-quarter and nine-month results through September 30, 2026.

agilon health, inc. 8-K event analysis

AI summary of each reported item and its exhibits

Item 2.02 · Results of Operations and Financial Condition

  • Press release covers agilon health’s third-quarter and nine-month results through September 30, 2026
  • Investors should review Exhibit 99.1 for reported financial performance and management commentary

Item EX-99.1 · Exhibit EX-99.1

  • Q3 revenue $1.52B, up 6% YoY despite total platform membership declining 8% to 566,000
  • MSER improved to 88.5% from 104.0%, driving net income $35M versus a $110M loss
  • Adjusted EBITDA reached $64M versus negative $91M, signaling substantial operating turnaround
  • FY2026 guidance raised: revenue $5.87B-$5.89B and Adjusted EBITDA $145M-$155M
  • Membership outlook remains lower, with year-end Medicare Advantage members guided to 445,000-450,000 and total platform members to 553,000-562,000

Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean

Other agilon health, inc. 8-K filings

Get the next AGL 8-K as it lands

Follow AGL for push alerts, or ask the research agent what this filing means.